Neslihan Abacı

8PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersAutoimmunityImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 10, 2026
DHRS2 regulates epithelial-mesenchymal transition in breast cancer cells.

|Jul 09, 2026
Investigation of advanced glycosylation end products, NF-κB activation, Nrf-2 rs35652124, rs6721961 regions on endoplasmic reticulum stress in peripheral artery disease.

|Sep 06, 2025
Integrated stress response in Behçet disease: expression analyses in peripheral blood and synovial monocytes.

İrem Coşkuntan, Ferda Paçal, Fulya Coşan

|May 21, 2025
NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis.

Vafa Guliyeva, Fatma Gül Demirkan, Erdem Bektaş

|Sep 15, 2022
The modulatory action of C-Vx substance on the immune system in COVID-19.

Ilhan Tahrali, Nilgun Akdeniz, Vuslat Yilmaz

|Jun 27, 2020
LEF1 Induces DHRS2 Gene Expression in Human Acute Leukemia Jurkat T-Cells

Sema Sırma Ekmekci, Zeliha Emrence, Neslihan Abacı

Pageof 2

Frequent Collaborators

7 joint publications

Sema Sırma Ekmekçi

3 joint publications

Ahmet Gül

3 joint publications

Zeliha Emrence

2 joint publications

Melda Sarıman